PTEN and neoplasm: We also used conditional melanocyte-specific expression of oncogenic Braf in combination with a conditional allele of the Pten tumor suppressor to decrease tumor latency (Dankort et al., 2009; Dhomen et al., 2009) (Figure 6—figure supplement 1A–B).